Literature DB >> 16926674

The relationship between higher blood pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians: meta-analysis.

Xiao-Fei Zhang1, John Attia, Catherine D'Este, Xiao-Yan Ma.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies have suggested that blood pressure is a particularly important risk factor for stroke in Chinese, and that the magnitude of the effect may be greater than in Caucasians. We performed a meta-analysis in order to define the magnitude of the risk of stroke associated with hypertension among Chinese, and to compare the magnitude of this risk with Caucasians.
METHODS: We searched Medline from 1966 to 2004, plus Chinese Medical Literature databases from 1977 to 2003 for Caucasian and Chinese studies. Results were pooled using the random effects model, and heterogeneity and publication bias were checked.
RESULTS: For a 10 mmHg increase in systolic blood pressure, the pooled risk ratio was 1.44 [95% confidence interval (CI)] 1.39-1.51 for ischaemic stroke, and 1.5 (95% CI 1.45-1.57) for haemorrhagic stroke in Chinese, versus 1.19 (95% CI 1.15-1.23) for total stroke in Caucasians. The pooled odds ratio for hypertension measured dichotomously (defined as > or =160/95 mmHg) was 5.8 (95% CI 4.7-7.2) among Chinese versus 1.93 (95% CI 1.7-2.2) among Caucasians for ischaemic stroke; and 7.2 (95% CI 5.3-9.7) in Chinese versus 3.1 (95% CI 2.5-3.9) in Caucasians for haemorrhagic stroke.
CONCLUSION: The risk of stroke associated with hypertension is consistently and significantly greater in Chinese than Caucasians. This may help genetic epidemiologists to dissect the cause of stroke, and emphasizes the particular importance of hypertension control in the Chinese population.

Entities:  

Mesh:

Year:  2006        PMID: 16926674     DOI: 10.1097/00149831-200606000-00020

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  7 in total

1.  Long-term outcome and prognostic factors after spontaneous cerebellar hemorrhage.

Authors:  Vincent Pong; Koon-Ho Chan; Boon-Hor Chong; Wai-Man Lui; Gilberto Ka-Kit Leung; Hung-Fat Tse; Jenny Kan-Suen Pu; Chung-Wah Siu
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study.

Authors:  Tsogzolmaa Dorjgochoo; Xiao Ou Shu; Xianglan Zhang; Honglan Li; Gong Yang; Lifeng Gao; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

Review 3.  Low glomerular filtration rate and risk of stroke: meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Kuo-Hsuan Chang; Hung-Wei Liao; Shen-Chih Chang; Bruce Ovbiagele
Journal:  BMJ       Date:  2010-09-30

4.  Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.

Authors:  Hui-lin Jiang; Cangel Pui-yee Chan; Yuk-ki Leung; Yun-mei Li; Colin A Graham; Timothy H Rainer
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Association of Chronic Kidney Disease With Small Vessel Disease in Patients With Hypertensive Intracerebral Hemorrhage.

Authors:  Yuan-Hsiung Tsai; Meng Lee; Leng-Chieh Lin; Sheng-Wei Chang; Hsu-Huei Weng; Jen-Tsung Yang; Yen-Chu Huang; Ming-Hsueh Lee
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

6.  Hypertension Prevalence, Health Service Utilization, and Participant Satisfaction: Findings From a Pilot Randomized Controlled Trial in Aged Chinese Canadians.

Authors:  Ping Zou; Cindy-Lee Dennis; Ruth Lee; Monica Parry
Journal:  Inquiry       Date:  2017-01-01       Impact factor: 1.730

7.  Exploring the causal pathway from ischemic stroke to atrial fibrillation: a network Mendelian randomization study.

Authors:  Lei Hou; Mingqing Xu; Yuanyuan Yu; Xiaoru Sun; Xinhui Liu; Lu Liu; Yunxia Li; Tonghui Yuan; Wenchao Li; Hongkai Li; Fuzhong Xue
Journal:  Mol Med       Date:  2020-01-15       Impact factor: 6.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.